[Long-term treatment of chronic rheumatoid arthritis with D-penicillamin (author's transl)]. 1977

G Tausch, and H Bröll, and R Eberl

UI MeSH Term Description Entries
D008134 Long-Term Care Care over an extended period, usually for a chronic condition or disability, requiring periodic, intermittent, or continuous care. Care, Long-Term,Long Term Care
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010396 Penicillamine 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease. Dimethylcysteine,Mercaptovaline,beta,beta-Dimethylcysteine,Copper Penicillaminate,Cuprenil,Cuprimine,D-3-Mercaptovaline,D-Penicillamine,Metalcaptase,D 3 Mercaptovaline,D Penicillamine,Penicillaminate, Copper,beta,beta Dimethylcysteine
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

G Tausch, and H Bröll, and R Eberl
November 1977, Medizinische Klinik,
G Tausch, and H Bröll, and R Eberl
July 1979, Klinische Padiatrie,
G Tausch, and H Bröll, and R Eberl
October 1979, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
G Tausch, and H Bröll, and R Eberl
February 1980, Ryumachi. [Rheumatism],
G Tausch, and H Bröll, and R Eberl
January 1969, Verhandlungen der Deutschen Gesellschaft fur Rheumatologie,
G Tausch, and H Bröll, and R Eberl
December 1975, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
G Tausch, and H Bröll, and R Eberl
February 1990, Acta neurologica Scandinavica,
G Tausch, and H Bröll, and R Eberl
August 1976, Nihon Jibiinkoka Gakkai kaiho,
G Tausch, and H Bröll, and R Eberl
February 1978, Rinsho byori. The Japanese journal of clinical pathology,
Copied contents to your clipboard!